Anatabloc lawsuit claims are now being investigated by Bernstein Liebhard LLP on behalf of consumers who purchased the pricy dietary supplement, which is purported by its manufacturer to treat various incurable and chronic medical disorders, ranging from Alzheimer’s disease to traumatic brain injury. In December 2013, the U.S. Food & Drug Administration (FDA) issued Star Scientific, Inc., the manufacturer of Anatabloc, a warning letter after finding that the company’s marketing materials made unfounded claims regarding the benefits supposedly associated with the supplement. The FDA also asserted that a key ingredient found in Anatabloc was a new food, and thus needed to be approved by the agency before it could be sold to the public.

Because of the questionable claims made by its manufacturer, consumers who purchased Anatabloc may be entitled to a refund of the purchase price, as well as other damages. Bernstein Liebhard LLP is now offering free Anatabloc lawsuit reviews to individuals who used this product, and is urging any consumer who purchased this dietary supplement to contact the Firm as soon as possible. Our legal staff will determine whether or not you have a valid claim against Star Pharmaceuticals and other potential defendants involved in the manufacture and marketing of Anatabloc, and will fully explain the legal process involved in seeking compensation from these companies through the filing of an Anatabloc lawsuit.

FDA Anatabloc Warning Letter

Anatabloc is dietary supplement that contains an ingredient called anatabine, along with Vitamin A and Vitamin D3. The product is manufactured by Star Scientific, Inc., a wholly-owned subsidiary of Rock Creek Pharmaceuticals Inc. The product, which retails for $99 per bottle of 300 tablets, is sold at GNC health and wellness stores.

Since April 2010, Star Scientific has issued more than a dozen press releases touting various company-backed studies that purported to show that anti-inflammatory properties associated with anatabine could mitigate the symptoms of various ailments, including Alzheimer’s disease, multiple sclerosis, thyroiditis,  traumatic brain injuries, inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis .

On December 20, 2013, the FDA issued a warning letter to Star Scientific, after finding that statements made by the company regarding anatabine’s anti-inflammatory properties were either unfounded or require new drug approval from the agency. Specifically, the agency took issue with statements on the company’s website that indicated the use of anatabine could aid in the treatment of IBD, Crohn’s disease and ulcerative colitis. The FDA also cited claims by the company regarding the ability of anatabine to mitigate the effects of traumatic brain injury.

On December 31, 2013, the FDA issued a Consumer Update to warn the public about companies that were marketing untested, unproven and possibly dangerous products that claim to prevent, treat or cure concussions and other traumatic brain injuries. The alert specifically cited the FDA warning letter issued to Star Scientific in relation to Anatabloc. The agency warned consumers to avoid using dietary supplements as treatments or cures for concussions and other traumatic brain injuries, as these claims are not backed by scientific evidence demonstrating that the products are safe or effective for such purposes.

Learn More about Filing an Anatabloc Lawsuit

Bernstein Liebhard LLP is now offering free, no -obligation legal reviews to consumers who purchased Anatabloc dietary supplements. If you would like to learn more about filing an Anatabloc lawsuit, please contact our office today by calling 1-877-779-1414 to speak with a member of our legal staff.

Published February 6, 2014 by